Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Pulse Biosciences Inc's Business Segments
Pulse Biosciences Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
1
Largest Segment
Single Reportable Segment
Total Revenue
$ 0
Regions Reported
-
Revenue Share by Reportable Segment - FY
- Single Reportable Segment0%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Single Reportable Segment | $ 1 | - |
Annual Results
Revenue Share by Reportable Segment - FY
- Single Reportable Segment0%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Single Reportable Segment | $ 1 | - |
Description of Pulse Biosciences Inc
Pulse Biosciences Inc. is a medical technology company that focuses on developing and commercializing innovative therapies based on its proprietary Nano-Pulse Stimulation (NPS) technology. The company was founded in 2014 and is headquartered in Hayward, California.
The NPS technology platform utilizes electrical energy to create controlled therapeutic tissue effects. It delivers a series of high-voltage and ultra-short electric pulses to target cells, selectively damaging their membranes while sparing the surrounding healthy tissues. This technology has the potential to treat a wide range of medical conditions, including cancer, dermatologic disorders, and other cellular-based diseases.
One of the primary applications of Pulse Biosciences' NPS technology is in the field of oncology. The company is developing the CellFX System, which is intended for the treatment of non-melanoma skin cancers, including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). The CellFX System combines a user interface, an energy delivery device, and a set of disposable treatment applicators to deliver the NPS energy to the targeted cells.
The CellFX System has received both the CE Mark in Europe and the FDA 510(k) clearance for commercial distribution in the United States. It has been designed to provide physicians with a precise, minimally invasive, and controllable treatment option for skin cancer patients. The technology's unique ability to selectively damage cancerous cells without affecting the surrounding healthy tissues has the potential to improve patient outcomes and reduce the risk of scarring or other adverse effects associated with traditional treatments like surgery or radiation therapy.
In addition to its focus on oncology, Pulse Biosciences is exploring other therapeutic areas where its NPS technology could be impactful. The company is conducting preclinical research and development programs to evaluate the potential of NPS technology in treating conditions such as acne, seborrheic keratosis, and various dermatologic disorders. It is also investigating the potential use of NPS in situations where targeted cellular ablation may be beneficial, such as in the treatment of chronic wounds or other challenging skin conditions.
Pulse Biosciences has a skilled team of scientists, engineers, and medical professionals who are dedicated to advancing the understanding and application of NPS technology. They are actively engaged in ongoing research, clinical trials, and collaborations with leading academic institutions and medical centers. By leveraging its expertise in the field of medical technology and its innovative NPS platform, Pulse Biosciences aims to improve patient outcomes and transform the way various diseases are treated.
The NPS technology platform utilizes electrical energy to create controlled therapeutic tissue effects. It delivers a series of high-voltage and ultra-short electric pulses to target cells, selectively damaging their membranes while sparing the surrounding healthy tissues. This technology has the potential to treat a wide range of medical conditions, including cancer, dermatologic disorders, and other cellular-based diseases.
One of the primary applications of Pulse Biosciences' NPS technology is in the field of oncology. The company is developing the CellFX System, which is intended for the treatment of non-melanoma skin cancers, including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). The CellFX System combines a user interface, an energy delivery device, and a set of disposable treatment applicators to deliver the NPS energy to the targeted cells.
The CellFX System has received both the CE Mark in Europe and the FDA 510(k) clearance for commercial distribution in the United States. It has been designed to provide physicians with a precise, minimally invasive, and controllable treatment option for skin cancer patients. The technology's unique ability to selectively damage cancerous cells without affecting the surrounding healthy tissues has the potential to improve patient outcomes and reduce the risk of scarring or other adverse effects associated with traditional treatments like surgery or radiation therapy.
In addition to its focus on oncology, Pulse Biosciences is exploring other therapeutic areas where its NPS technology could be impactful. The company is conducting preclinical research and development programs to evaluate the potential of NPS technology in treating conditions such as acne, seborrheic keratosis, and various dermatologic disorders. It is also investigating the potential use of NPS in situations where targeted cellular ablation may be beneficial, such as in the treatment of chronic wounds or other challenging skin conditions.
Pulse Biosciences has a skilled team of scientists, engineers, and medical professionals who are dedicated to advancing the understanding and application of NPS technology. They are actively engaged in ongoing research, clinical trials, and collaborations with leading academic institutions and medical centers. By leveraging its expertise in the field of medical technology and its innovative NPS platform, Pulse Biosciences aims to improve patient outcomes and transform the way various diseases are treated.
Pulse Biosciences, Inc. is a biotechnology company that focuses on making significant advances in the field of therapeutic and cosmetic applications using its unique technology known as Nano-Pulse Stimulation (NPS). This technology facilitates the targeted delivery of precise energy fields to cells, which can result in selective cellular responses. The company operates primarily in two main segments: therapeutic products and aesthetic/cosmetic products.
1. Therapeutic Products
A. Cancer Treatment
Pulse Biosciences is developing therapeutic applications for NPS that target cancer cells. This approach aims to provide a non-invasive treatment option that minimizes damage to surrounding healthy tissues, potentially leading to fewer side effects compared to traditional cancer treatments like chemotherapy or radiation. By applying NPS to tumors, the technology may help induce apoptosis (programmed cell death) in malignant cells while sparing normal cells, thus improving treatment outcomes for patients suffering from various cancer types.
B. Wound Healing
Another important segment of Pulse Biosciences’ therapeutic offerings is in wound care. The company is exploring the use of NPS for the treatment of chronic wounds, such as diabetic ulcers and other difficult-to-heal skin lesions. The technology has shown promise in promoting healing through cellular regeneration and modulating the inflammatory response, which can expedite recovery and improve the quality of life for patients with chronic wounds.
C. Other Medical Applications
In addition to cancer treatment and wound healing, Pulse Biosciences is also looking into other medical conditions that could benefit from its NPS technology, including dermatological diseases, autoimmune disorders, and systemic inflammatory conditions. The versatility of the NPS technology allows for innovative treatments aimed at improving patient outcomes across a range of medical issues.
Aesthetic / Cosmetic Products
A. Skin Rejuvenation
The aesthetic segment of Pulse Biosciences leverages the NPS technology for cosmetic applications, specifically in skin rejuvenation treatments. This includes non-invasive procedures designed to reduce the appearance of fine lines, wrinkles, and other signs of aging. The targeted stimulation of skin cells can promote collagen production and enhance skin texture and tone, offering a more youthful appearance to patients.
B. Hair Restoration
Pulse Biosciences has been expanding its portfolio to include hair restoration solutions using NPS. This application targets hair follicles in a non-invasive manner, aiming to stimulate hair growth in individuals experiencing hair thinning or loss. The non-invasive nature of the procedure allows for a more comfortable experience and reduces downtime compared to traditional hair restoration techniques.
C. Pigmentation Treatments
Another cosmetic application being explored by Pulse Biosciences is the treatment of skin pigmentation issues, such as age spots, melasma, and other hyperpigmentation conditions. By utilizing NPS, the company aims to provide a solution that safely lightens pigmented areas of the skin without causing harm to the surrounding tissue.
Research and Development Services
In addition to its core product offerings, Pulse Biosciences invests substantially in research and development (R&D) to explore new applications of its proprietary technology. The company collaborates with academic institutions and other industry stakeholders to advance its understanding of NPS and its potential therapeutic and cosmetic applications. This R&D focus is crucial for the continual innovation and refinement of existing products and services, as well as the introduction of new offerings in the evolving biotech landscape.
Conclusion
Pulse Biosciences, Inc. is at the forefront of utilizing its proprietary Nano-Pulse Stimulation technology across diverse segments, including medical therapies and cosmetic enhancements. With a strong emphasis on non-invasive applications, the company aims to transform patient care and aesthetic procedures through innovative solutions that promote efficacy and enhance safety. The ongoing R&D efforts underscore the company’s commitment to pushing the boundaries of what is possible in biotechnology and aesthetic treatments.
1. Therapeutic Products
A. Cancer Treatment
Pulse Biosciences is developing therapeutic applications for NPS that target cancer cells. This approach aims to provide a non-invasive treatment option that minimizes damage to surrounding healthy tissues, potentially leading to fewer side effects compared to traditional cancer treatments like chemotherapy or radiation. By applying NPS to tumors, the technology may help induce apoptosis (programmed cell death) in malignant cells while sparing normal cells, thus improving treatment outcomes for patients suffering from various cancer types.
B. Wound Healing
Another important segment of Pulse Biosciences’ therapeutic offerings is in wound care. The company is exploring the use of NPS for the treatment of chronic wounds, such as diabetic ulcers and other difficult-to-heal skin lesions. The technology has shown promise in promoting healing through cellular regeneration and modulating the inflammatory response, which can expedite recovery and improve the quality of life for patients with chronic wounds.
C. Other Medical Applications
In addition to cancer treatment and wound healing, Pulse Biosciences is also looking into other medical conditions that could benefit from its NPS technology, including dermatological diseases, autoimmune disorders, and systemic inflammatory conditions. The versatility of the NPS technology allows for innovative treatments aimed at improving patient outcomes across a range of medical issues.
Aesthetic / Cosmetic Products
A. Skin Rejuvenation
The aesthetic segment of Pulse Biosciences leverages the NPS technology for cosmetic applications, specifically in skin rejuvenation treatments. This includes non-invasive procedures designed to reduce the appearance of fine lines, wrinkles, and other signs of aging. The targeted stimulation of skin cells can promote collagen production and enhance skin texture and tone, offering a more youthful appearance to patients.
B. Hair Restoration
Pulse Biosciences has been expanding its portfolio to include hair restoration solutions using NPS. This application targets hair follicles in a non-invasive manner, aiming to stimulate hair growth in individuals experiencing hair thinning or loss. The non-invasive nature of the procedure allows for a more comfortable experience and reduces downtime compared to traditional hair restoration techniques.
C. Pigmentation Treatments
Another cosmetic application being explored by Pulse Biosciences is the treatment of skin pigmentation issues, such as age spots, melasma, and other hyperpigmentation conditions. By utilizing NPS, the company aims to provide a solution that safely lightens pigmented areas of the skin without causing harm to the surrounding tissue.
Research and Development Services
In addition to its core product offerings, Pulse Biosciences invests substantially in research and development (R&D) to explore new applications of its proprietary technology. The company collaborates with academic institutions and other industry stakeholders to advance its understanding of NPS and its potential therapeutic and cosmetic applications. This R&D focus is crucial for the continual innovation and refinement of existing products and services, as well as the introduction of new offerings in the evolving biotech landscape.
Conclusion
Pulse Biosciences, Inc. is at the forefront of utilizing its proprietary Nano-Pulse Stimulation technology across diverse segments, including medical therapies and cosmetic enhancements. With a strong emphasis on non-invasive applications, the company aims to transform patient care and aesthetic procedures through innovative solutions that promote efficacy and enhance safety. The ongoing R&D efforts underscore the company’s commitment to pushing the boundaries of what is possible in biotechnology and aesthetic treatments.